Event-Driven Stocks

UNIGENE LABORATORIES INC

Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕

Signs2 good5 warning3 severedetails ↓

Financials

SEC XBRL · annual
 FY12FY11FY10FY09
Revenue$9.4M$20.5M$11.3M$12.8M
Operating income−$9.4M−$3.5M−$10.3M−$12.4M
Net income−$34.3M−$7.1M−$32.5M−$13.4M
Total assets$11.3M$18.2M$28.5M
Total liabilities$110.1M$83.9M$68.9M
Equity−$98.7M−$65.7M−$61.8M
EPS (diluted)$-0.19$-0.30$-0.15
Shares out.95.4M95.2M92.4M90.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2012
Operating margin
−99.3%
Net margin
−363.3%
Return on equity
34.7%
Return on assets
−303.1%
Return on capital (ROCE)
Liabilities / assets
972.8%
Debt / equity
Book value / share
$-1.04
Revenue growth (YoY)
−54.0%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2012
Altman Z″ (distress)
-126.24distress
Accruals / assets
275.0%clean
Beneish M-Score
-17.21normal
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
25
/ 100
Profitability 25Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 severe5 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)